Celgene (CELG) volatility elevated into acquiring Juno Therapeutics for approximately $87 per share in cash

Celgene (NASDAQ: CELG) January weekly call option implied volatility is at 46, February is at 33; compared to its 52-week range of 17 to 38 into acquiring Juno Therapeutics (JUNO) for approximately $87 per share in cash.

You May Also Be Interested In

• Allison Transmission to Join S&P MidCap 400; Goodyear Tire & Rubber to Join S&P SmallCap 600
• Interpool (IPX) 2100 contracts of July 35 calls trade, share price up 12%
• National Energy Services Reunited Corp. (NESR) 5400 contracts of July 35 calls trade, share price up 3.9%